News for Pharming Group Stock (PHAR)

Pharming Group announces the placement of €100 million convertible bonds due 2029

GlobeNewsWire • Thursday

Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025

GlobeNewsWire • Thursday

Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

GlobeNewsWire • 04/08/24

Pharming Group announces the 2024 Annual General Meeting of Shareholders

GlobeNewsWire • 04/04/24

Pharming Group announces the filing of its 2023 Annual Report and Form 20-F

GlobeNewsWire • 04/04/24

Pharming Group N.V. (PHAR) Q4 2023 Earnings Call Transcript

Seeking Alpha • 03/14/24

Pharming Group reports fourth quarter and full year 2023 financial results

GlobeNewsWire • 03/14/24

Pharming Group to report fourth quarter and full year 2023 financial results on March 14

GlobeNewsWire • 02/29/24

Pharming Group to participate in February investor conferences

GlobeNewsWire • 02/08/24

Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update

GlobeNewsWire • 01/08/24

Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)

GlobeNewsWire • 12/13/23

Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval

GlobeNewsWire • 11/10/23

Pharming Group announces presentations at International Primary Immunodeficiencies Congress and the American College of Allergy, Asthma & Immunology Annual Scientific Meeting

GlobeNewsWire • 11/07/23

Pharming Group to participate in November investor conferences

GlobeNewsWire • 11/01/23

Pharming Group N.V. (PHAR) Q3 2023 Earnings Call Transcript

Seeking Alpha • 10/27/23

Pharming Group N.V. (PHGUF) Q3 2023 Earnings Call Transcript

Seeking Alpha • 10/27/23

Pharming Group reports third quarter 2023 financial results

GlobeNewsWire • 10/26/23

Pharming Group to report third quarter 2023 financial results on October 26

GlobeNewsWire • 10/12/23

Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders

GlobeNewsWire • 09/25/23

Pharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock?

Zacks Investment Research • 09/22/23

Pharming Group: Pipeline Progresses With APDS Phase 3 Initiation

Seeking Alpha • 09/09/23

Pharming Group to participate in September investor conferences

PRNewsWire • 08/24/23

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan

PRNewsWire • 08/09/23

Pharming Group N.V. (PHAR) Q2 2023 Earnings Call Transcript

Seeking Alpha • 08/06/23

Pharming Group N.V. (PHGUF) Q2 2023 Earnings Call Transcript

Seeking Alpha • 08/06/23